Anavex Life Sciences (AVXL) Stock Price, Quote, News & History

Comments

Anavex Life Sciences Corp (AVXL) Stock Price, Quote, News & History

AVXLNASDAQ

Trade with Public

$4.65

-0.11-2.31%

At close: Mar 5, 4:00 PM EST

$4.60

-0.16-3.36%

Pre-Market: 7:00 AM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

1.00 / 1.63M

Day Range

- - -

52 Wk Range

2.86 - 13.99

Market Cap

$426.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

23.06%

Days to Cover

13.17

Recent Anavex Life Sciences Corp News

What's Going On With Anavex Life Sciences Stock On Wednesday?

Anavex Life Sciences' stock rises despite no news, up over 40% this year as investors watch Alzheimer's program updates and analyst targets.

Vandana Singh

Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Top Stocks with Earnings This Week: Costco, MongoDB, Ulta and More

Retail investors are prepping for a lighter week of corporate earnings featuring Costco, MongoDB, Ulta and more.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-39.04M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

9.43M

Free Cash Flow (TTM)

-39.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-29.61M

Analyst Trends and Forecast

4

Nov 25

3

Dec 25

1

Jan

2

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$279.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.40

Earnings Yield % (TTM)

-9.89%

Earnings Yield % (FWD)

-6.99%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.37

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$102.58M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

1.00 / 1.63M

Day Range

- - -

52 Wk Range

2.86 - 13.99

Market Cap

$426.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

23.06%

Days to Cover

13.17

About

Sector

Health Care

Industry

Biotechnology

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data fr...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Anavex Life Sciences (AVXL) stock?

A

You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Anavex Life Sciences (AVXL) competitors?

A

Other companies in Anavex Life Sciences’s space includes: 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Upstream Bio Inc (NASDAQ:UPB), Monopar Therapeutics Inc (NASDAQ:MNPR), Larimar Therapeutics Inc (NASDAQ:LRMR) and Altimmune Inc (NASDAQ:ALT).

Q

What is the forecast, or price target, for Anavex Life Sciences (AVXL) stock?

A

Anavex Life Sciences has a consensus price target of $30.00.

Q

What is the current price for Anavex Life Sciences (AVXL)?

A

The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $4.6 last updated March 6, 2026 at 5:59 PM EST.

Q

Does Anavex Life Sciences (AVXL) pay a dividend?

A

There are no upcoming dividends for Anavex Life Sciences.

Q

When is Anavex Life Sciences (NASDAQ:AVXL) reporting earnings?

A

Anavex Life Sciences does not have any upcoming earnings scheduled.

Q

Is Anavex Life Sciences (AVXL) going to split?

A

There is no upcoming split for Anavex Life Sciences.

Q

What sector and industry does Anavex Life Sciences (AVXL) operate in?

A

Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

4D Molecular Therapeutics Inc

Monopar Therapeutics Inc

NASDAQ:MNPR

$57.61

%

Larimar Therapeutics Inc

Armata Pharmaceuticals Inc

AMEX:ARMP

$10.73

1.21%

DiaMedica Therapeutics Inc

NASDAQ:DMAC

$7.71

%

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

1.00 / 1.63M

Day Range

- - -

52 Wk Range

2.86 - 13.99

Market Cap

$426.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

23.06%

Days to Cover

13.17

Recent Anavex Life Sciences Corp News

What's Going On With Anavex Life Sciences Stock On Wednesday?

Anavex Life Sciences' stock rises despite no news, up over 40% this year as investors watch Alzheimer's program updates and analyst targets.

Vandana Singh

Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Top Stocks with Earnings This Week: Costco, MongoDB, Ulta and More

Retail investors are prepping for a lighter week of corporate earnings featuring Costco, MongoDB, Ulta and more.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-39.04M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

9.43M

Free Cash Flow (TTM)

-39.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-29.61M

Analyst Trends and Forecast

4

Nov 25

3

Dec 25

1

Jan

2

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$279.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.40

Earnings Yield % (TTM)

-9.89%

Earnings Yield % (FWD)

-6.99%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.37

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$102.58M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

1.00 / 1.63M

Day Range

- - -

52 Wk Range

2.86 - 13.99

Market Cap

$426.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

23.06%

Days to Cover

13.17

About

Sector

Health Care

Industry

Biotechnology

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data fr...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry